The utility of PSA doubling time to monitor prostate cancer recurrence

被引：0
|
作者：
Wieder, JA [1 ]
Belldegrun, AS [1 ]
机构：
[1] Univ Calif Los Angeles, Dept Urol, Sch Med, Los Angeles, CA 90095 USA
来源：
MAYO CLINIC PROCEEDINGS | 2001年 / 76卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：571 / 572
页数：2
相关论文
共 50 条
  • [21] PSA doubling time calculated early on following PSA relapse predicts for subsequent death from prostate cancer
    Pickles, T.
    Tyldesley, S.
    Kim-Sing, C.
    EJC SUPPLEMENTS, 2005, 3 (02): : 231 - 231
  • [22] Prostate cancer recurrence in the urethra with low PSA
    Ananthapadmanabhan, Shravankrishna
    Williams, Zoe
    Wang, Henry
    Combes, Alexander
    Wong, Veronica
    Thangasamy, Isaac
    UROLOGY CASE REPORTS, 2024, 55
  • [23] A Review on the Clinical Utility of PSA in Cancer Prostate
    Mohan Adhyam
    Anish Kumar Gupta
    Indian Journal of Surgical Oncology, 2012, 3 (2) : 120 - 129
  • [24] A Review on the Clinical Utility of PSA Cancer Prostate
    Adhyam, Mohan
    Gupta, Anish Kumar
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2012, 3 (02) : 120 - 129
  • [25] PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time
    Ciezki, JP
    Reddy, CA
    Garcia, J
    Angermeier, K
    Ulchaker, J
    Mahadevan, A
    Chehade, N
    Altman, A
    Klein, EA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (02): : 512 - 517
  • [26] PSA kinetics following prostate brachytherapy: The PSA bounce phenomenon and its implications for PSA doubling time
    Ciezki, J
    Reddy, C
    Jorge, G
    Klein, E
    Angermeier, K
    Ulchaker, J
    Mahadevan, A
    Chehade, N
    Altman, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S317 - S318
  • [27] Predicting bone scan positivity: the utility of PSA doubling time versus absolute PSA levels
    Preece, P.
    Yao, H.
    Liew, D.
    Mcmullin, R.
    BJU INTERNATIONAL, 2013, 111 : 91 - 91
  • [28] PSA DOUBLING TIME PREDICTS OUTCOME AFTER ACTIVE SURVEILLANCE IN SCREENING DETECTED PROSTATE CANCER
    Axen, E.
    Hugosson, J.
    Khatami, A.
    Lodding, P.
    Stranne, J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 236 - 236
  • [29] PSA doubling time thresholds in predicting clinical recurrence after biochemical recurrence in surgically treated prostate cancer patients. The Impact of nodal status and adjuvant radiotherapy
    Nocera, L.
    Mazzone, E.
    Scuderi, S.
    Barletta, F.
    Cannoletta, D.
    Quarta, L.
    Pellegrino, A.
    Pellegrino, F.
    Scilipoti, P.
    Sorce, G.
    Leni, R.
    Longoni, M.
    Cirulli, G. O.
    Cucchiara, V.
    Robesti, D.
    Gandaglia, G.
    Montorsi, F.
    Briganti, A.
    EUROPEAN UROLOGY, 2024, 85 : S1530 - S1531
  • [30] Effect of fulvestrant on PSA doubling time in patients with castration-resistant prostate cancer (CRPC)
    Srinivas, S.
    Harshman, L. C.
    Feldman, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345